Answers are grounded in this paper and cite their sources.
The study identified a novel MH-susceptibility allele (7025A>G in RYR1) but did not find conclusive evidence that malignant hyperthermia and hypokalemic periodic paralysis share a common genetic determinant.
Hypokalemic periodic paralysis (HypoPP) and malignant hyperthermia (MH) are autosomal-dominant genetically heterogeneous ion channelopathies. MH has been described in patients with HypoPP, suggesting a potential link between these disorders. However, a common genetic determinant has not been described. With the aim of corroborating this association, four candidate genes were screened in two independent HypoPP patients, one of whom was also diagnosed as MH-susceptible and the other as MH-normal by the in vitro contracture test (IVCT). An A>G change at nucleotide 7025 was detected in the RYR1 gene in the HypoPP/MH-susceptible patient. Detection of the same mutation in three independent MH families suggested that 7025A>G represents a novel MH-susceptibility allele and that MH and HypoPP occurred independently in the case presented. Conclusive evidence in support of the hypothesis that MH and HypoPP are allelic was therefore not obtained.
No takes yet. Share an insight, caveat, or question.
Marchant et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: